Substance / Medication

Lofexidine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
[Antipsychotic Treatment of Alcohol Withdrawal Syndrome with Focus on Delirium Tremens: a Systematic Review].
Faustmann Timo Jendrik, Paschali Myrella, Kojda Georg et al. · Fortschr Neurol Psychiatr · 2025
PMID: 36958342Meta-Analysis
Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review.
Gregory Caroline, Yadav Krishan, Linders Jordyn et al. · Addiction · 2025
PMID: 39322991Meta-Analysis
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.
Zhang Mi-Mi, Tan Xuan, Zheng Yong-Bo et al. · Mol Psychiatry · 2025
PMID: 39394455Meta-Analysis
The Role of Propofol in Alcohol Withdrawal Syndrome: A Systematic Review.
Shirk Logan, Reinert Justin P · J Clin Pharmacol · 2025
PMID: 39415533Meta-AnalysisFull text (PMC)
Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms.
Stimpfl Julia N, Walkup John T, Robb Adelaide S et al. · J Child Adolesc Psychopharmacol · 2025
PMID: 39469761Meta-AnalysisFull text (PMC)
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series.
Eserian Jaqueline K, Blanco Vinícius P, Mercuri Lucildes P et al. · Pharmacopsychiatry · 2025
PMID: 39532152Meta-Analysis
Ethanol for the management of alcohol withdrawal syndrome: a systematic review.
Quelch Darren, Davies Nyle, McFauld Claire et al. · Clin Toxicol (Phila) · 2025
PMID: 39559850Meta-Analysis
Pharmacokinetics of lofexidine hydrochloride in healthy volunteers.
Al-Ghananeem Abeer M · J Pharm Sci · 2009
PMID: 18393298Observational
Clinical Efficacy and Safety Profile of Lofexidine Hydrochloride in Treating Opioid Withdrawal Symptoms: A Review of Literature.
Rehman Saif Ur, Maqsood Muhammad Haisum, Bajwa Hamza et al. · Cureus · 2019
PMID: 31403015ReviewFull text (PMC)
Randomized placebo controlled trial of lofexidine hydrochloride for chronic pelvic pain in women.
Stones R W, Bradbury L, Anderson D · Hum Reprod · 2001
PMID: 11473971Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lofexidine hydrochloride (substance)
SNOMED CT
395773009
UMLS CUI
C0771049

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.